Literature DB >> 25824461

Down-regulation of Homer1b/c protects against chemically induced seizures through inhibition of mTOR signaling.

Lei Cao1, Ye Tian, Yi Jiang, Ge-Juan Zhang, Hui Lei, Zheng-Li Di.   

Abstract

BACKGROUND: Homer is a family of post synaptic density proteins functionally and physically attached to target proteins at proline-rich sequences. Reducing Homer1b/c expression has been shown in previous studies to be protective against excitotoxic insults, implicating Homer1b/c in the physiological regulation of aberrant neuronal excitability.
METHODS: To test the efficacy of a Homer1b/c reducing therapy for disorders with a detrimental hyperexcitability profile in mice, we used small interfere RNA (siRNA) to decrease endogenous Homer1b/c expression in mouse hippocampus. The baseline motor and cognitive behavior was measured by sensorimotor tests, Morris water maze and elevated plus maze tasks. The anti-epileptic effects of Homer1b/c knockdown were determined in two chemically induced seizure models induced by Picrotoxin (PTX) or pentylenetetrazole (PTZ) administration.
RESULTS: The results of sensorimotor tests, Morris water maze and elevated plus maze tasks showed that Homer1b/c reduction had no effect on baseline motor or cognitive behavior. In two chemically induced seizure models, mice with reduced Homerb/c protein had less severe seizures than control mice. Total Homer1b/c protein levels and seizure severity were highly correlated, such that those mice with the most severe seizures also had the highest levels of Homer1b/c. In addition, the phosphorylation of mammalian target of rapamycin (mTOR) and its target protein S6 was significantly inhibited in Homer1b/c down-regulated mice. Homer1b/c knockdown-induced inhibition of mTOR pathway was partially ablated by the metabotropic glutamate receptor 5 (mGluR5) agonist CHPG.
CONCLUSION: Our results demonstrate that endogenous Homer1b/c is integral for regulating neuronal hyperexcitability in adult animals and suggest that reduction of Homer1b/c could protect against chemically induced seizures through inhibition mTOR pathway.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25824461     DOI: 10.1159/000373977

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  5 in total

Review 1.  Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy.

Authors:  Samuel A Barnes; Douglas J Sheffler; Svetlana Semenova; Nicholas D P Cosford; Anton Bespalov
Journal:  Biol Psychiatry       Date:  2018-03-09       Impact factor: 13.382

2.  A bidirectional competitive interaction between circHomer1 and Homer1b within the orbitofrontal cortex regulates reversal learning.

Authors:  Alexander K Hafez; Amber J Zimmerman; Grigorios Papageorgiou; Jayapriya Chandrasekaran; Stephen K Amoah; Rixing Lin; Evelyn Lozano; Caroline Pierotti; Michela Dell'Orco; Brigham J Hartley; Begüm Alural; Jasmin Lalonde; John Matthew Esposito; Sabina Berretta; Alessio Squassina; Caterina Chillotti; Georgios Voloudakis; Zhiping Shao; John F Fullard; Kristen J Brennand; Gustavo Turecki; Panos Roussos; Roy H Perlis; Stephen J Haggarty; Nora Perrone-Bizzozero; Jonathan L Brigman; Nikolaos Mellios
Journal:  Cell Rep       Date:  2022-01-18       Impact factor: 9.995

3.  Corrigendum: A Simplified In vitro Experimental Model Encompasses the Essential Features of Sleep.

Authors:  Ilaria Colombi; Federico Tinarelli; Valentina Pasquale; Valter Tucci; Michela Chiappalone
Journal:  Front Neurosci       Date:  2016-09-07       Impact factor: 4.677

4.  Effects of mTOR on Neurological Deficits after Transient Global Ischemia.

Authors:  Jihong Xing; Jian Lu
Journal:  Transl Neurosci       Date:  2017-04-30       Impact factor: 1.757

5.  mTOR is involved in stroke-induced seizures and the anti-seizure effect of mild hypothermia.

Authors:  Guo-Shuai Yang; Xiao-Yan Zhou; Xue-Fang An; Xuan-Jun Liu; Yan-Jun Zhang; Dan Yu
Journal:  Mol Med Rep       Date:  2018-02-22       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.